Skip to content
FrontierPicks

Dossier · ANDG · Dormant

ANDG · Andersen Group Inc. · Stock research

Last analysed ·

Current thesis

Post-IPO roll-up re-rate that survived its binary: Q2 revenue $217.7M beat $199.3M on 2026-08-12 and FY2026 was affirmed at $980M–$1.0B, with four target raises to $49–57 on 2026-08-13. The print is behind it and no dated catalyst sits inside 30 days; the leg now depends on 16 deals worth ~$134M annualized converting into a raise, on a 10.72M float that is 26.7% short.

Kill line

A weekly close below $42.50 surrenders the July breakout shelf and the rising 50-day average near $41.94; secondary, FY2026 revenue guidance trimmed under the $980M floor or a Q3 adjusted EBITDA margin that fails to recover toward the 23–25% band from Q2's 21.1%.

Pick status

Open commitment scored if the kill line above fires How this is scored →

Latest analysis and events for ANDG —

As of 16 August 2026, the latest FrontierPicks analysis for Andersen Group Inc. (ANDG): Post-IPO roll-up re-rate that survived its binary: Q2 revenue $217.7M beat $199.3M on 2026-08-12 and FY2026 was affirmed at $980M–$1.0B, with four target raises to $49–57 on 2026-08-13. The print is behind it and no dated catalyst sits inside 30 days; the leg now depends on 16 deals worth ~$134M annualized converting into a raise, on a 10.72M float that is 26.7% short.

Kill line: A weekly close below $42.50 surrenders the July breakout shelf and the rising 50-day average near $41.94; secondary, FY2026 revenue guidance trimmed under the $980M floor or a Q3 adjusted EBITDA margin that fails to recover toward the 23–25% band from Q2's 21.1%.

Current Thesis

  • The binary flagged in the prior note resolved on 2026-08-12. Q2 2026 revenue came in at $217.7M, +23.7% from $176.0M a year earlier, against a $199.31M consensus. Adjusted EBITDA was $45.96M at a 21.1% margin, a 420bp year-on-year expansion. GAAP diluted EPS was $(0.09) on a $(10.1)M net loss (Andersen Q2 2026 results release).
  • FY2026 guidance was reaffirmed, not raised: $980M–$1.0B revenue (~18% growth), adjusted EBITDA $225–250M, margin 23–25%. That is the most consequential line in the print, because between 2026-08-10 and 2026-08-11 the company announced deals adding roughly $94.5M of annualized revenue and put the 2026 total at 16 acquisitions worth approximately $134M annualized.
  • The leg an investor is buying: mid-to-high-teens organic fee growth in tax and valuation advisory, compounded by a country-by-country and service-line bolt-on engine, repriced from a $16.00 IPO (2025-12-17) onto a public growth multiple, with price discovered on a 10.72M-share float against 112.99M shares outstanding.
  • The narrative is maturing. Dating it — the 2026-08-12 print beat on revenue and held the guide; the 2026-08-13 analyst batch lifted targets (Baird $57 Outperform, Truist $55 Buy, Morgan Stanley $54 Equal-Weight, Wells Fargo $49 Equal-Weight) with no rating upgrades in the group; short interest was 2.86M shares versus 2.87M the prior month (stockanalysis.com, 2026-08-16), so the print forced no covering. Coverage is established and flow is moderating while price still works — a step down from the accelerating read carried into 2026-07-31.

Bullish and bearish views on Andersen Group Inc.

The model's bull view on Andersen Group Inc. (ANDG), in brief: Growth accelerated rather than decayed through the seasonal trough: Q2 revenue +23.7% YoY versus +15.7% in Q1 2026 and +14.6% for FY2025. The bear view: A guide affirmed while $134M of annualized acquired revenue is announced in the same year implies either deliberate conservatism or organic deceleration inside the FY range. Both cases follow in full.

Bull Case

  • Growth accelerated rather than decayed through the seasonal trough: Q2 revenue +23.7% YoY versus +15.7% in Q1 2026 and +14.6% for FY2025. Six-month revenue $458.4M, +19.4% from $384.1M (release, 2026-08-12). Coverage of the 2026-08-12 call put organic growth at 20.6%.
  • The acquisition engine ran hot in August: Andersen Mexico plus five U.S. consulting firms — Clareo, BD Emerson, Daniels Consulting Group, Endeavor Management and Zenger Folkman — announced 2026-08-10 at roughly $34.5M annualized; UK Andersen LLP and SPR Consulting announced 2026-08-11 at roughly $60M annualized. Management said eight further acquisitions are expected to close in Q4 2026.
  • Adjusted profitability is scaling: Q2 adjusted net income $39.0M, +38.8% YoY; six-month adjusted net income $106.3M, +27.5%; six-month adjusted EBITDA margin 26.8%. Equity-based compensation fell to $48.3M in Q2 2026 from $129.6M in Q2 2025.
  • Balance sheet supports the cadence without a raise: $175.6M cash plus $2.1M of treasuries at 2026-06-30, alongside the $50M three-year JPMorgan asset-based revolver signed 2026-06-25 at Term SOFR + 1.75% (8-K, 2026-06-29).
  • The valuation objection from July has been retired by the street itself. The 2026-08-14 close of $48.89 sits below all four targets published on 2026-08-13, where the pre-print consensus target was $40.50 across 7 analysts (2026-07-24).

Bear Case

  • A guide affirmed while $134M of annualized acquired revenue is announced in the same year implies either deliberate conservatism or organic deceleration inside the FY range. Nothing in the 2026-08-12 release resolves which.
  • Q2 adjusted EBITDA margin of 21.1% sits below the 23–25% full-year band. The second half has to carry the difference, in a business whose seasonality already front-loads margin into Q1.
  • GAAP has still not turned: $(10.1)M net loss in Q2 on $48.3M of equity comp. Screens requiring GAAP profitability keep excluding the name.
  • Supply is unrestricted. The IPO lock-up expired 2026-06-15, and a fund advised by Durable Capital Partners sold 336,736 Class A shares at an average $40.01 (Form 4, filed around 2026-07-09). Up-C unit exchanges can convert non-tradable units into Class A float at holders' election.
  • Two of the four 2026-08-13 target raises came from Equal-Weight-rated desks. Targets moved toward the price; the ratings did not move toward the story.
  • Sixteen acquisitions in one calendar year is an integration load. Reported U.S. attrition was 15.7% in Q2 against 2,690 employees and 349 Managing Directors at 2026-06-30.

Setup & Price Structure

  • Reference close 2026-08-14: $48.89, RSI(14) 58.9, three-month return +39.3%. The prior intraday all-time high was $48.32 on 2026-07-27, so the name is closing above its pre-print record.
  • The 50-day average was $41.94 as of 2026-08-16 (stockanalysis.com). The 2026-07-27 breakout session travelled $43.33 to $48.32 and closed +9.62% at $46.94; that range is the shelf the July advance was built on.
  • Momentum observable: RSI(14) read 65.94 at a $47.33 close on 2026-07-31 and 58.9 at a higher $48.89 close on 2026-08-14. Price made a new high on a cooler oscillator — expanding price, moderating thrust.
  • Crowding evidence, stated as observables: short interest 2.86M shares, 26.72% of a 10.72M float, 6.74 days to cover, versus 2.87M the prior month (2026-08-16); institutional ownership screens at 112.3% of float, an artifact of the Up-C share structure rather than a real figure; enterprise value $5.76B, price/sales 6.05, forward P/E 25.17.
  • The near-term calendar is empty. The event that carried the June–August advance has passed; the next scheduled company disclosure of consequence is the Q3 print, outside 30 days.

Catalyst Calendar (next 30 days)

  • ~2026-09-10 (est.) — FINRA short-interest report for the 2026-08-31 settlement date. First clean post-print reading on whether the 26.72%-of-float short position changed after the revenue beat.
  • ~2026-11-11 (est.) — Q3 2026 results. Outside the 30-day window, but the print where second-half margin recovery toward 23–25% and any FY guidance revision land.

Elapsed catalysts

  • ~2026-08-19 (est.) — Q2 2026 Form 10-Q. First full reporting period after the 2026-06-15 lock-up expiry; shows any draw on the $50M JPMorgan revolver, purchase accounting for the 2026 acquisition cohort, and any Class B/LLC unit exchanges converting into Class A float. (passed 7d ago)
  • Rolling, undated — further acquisition announcements. Deals were announced on 2026-08-10 and 2026-08-11 with eight more guided to close in Q4 2026; the cadence has been roughly monthly through 2026 and is the main source of unscheduled headlines. (passed 15d ago)

What Would Change Our Mind

  • Losing the July structure is the first break. The 2026-07-27 breakout shelf near $43 and the rising 50-day average at $41.94 (2026-08-16) define the base built after the 2026-05-12 guidance raise; a weekly close below $42.50 surrenders both and turns the post-print high into a failed breakout.
  • The fundamental break is a guidance cut beneath the $980M FY2026 revenue floor, or a Q3 adjusted EBITDA margin that does not recover toward the 23–25% band from the 21.1% posted in Q2.
  • A disclosure break: an organic-versus-acquired revenue split showing organic growth materially below the 20.6% figure cited on the 2026-08-12 call, which would reframe the multiple as paying for purchased revenue.
  • A supply break: a resale registration statement, a follow-on, or further top-holder reductions above $45 following the Durable Capital sale at $40.01.
  • Flow evidence would also matter — if the theme flips to saturated, marked by mainstream coverage arriving while short interest keeps falling without price progress, the remaining bid thins.

Correlation Notes

  • Listed professional-services consolidators — CBIZ, FTI Consulting, Huron Consulting, CRA International, ICF International — are the sector read-across, but a 10.72M-share float transmits sector moves weakly. Single-name flow dominates.
  • The bolt-on engine is partly rate-sensitive through the Term SOFR + 1.75% revolver (2026-06-25). A higher-for-longer front end raises the cost of the acquisition cadence that supplied roughly $134M of announced annualized revenue in 2026.
  • The name shares a narrative channel with AI-exposed billable-hour businesses: a large consultancy or staffing firm guiding down on AI-driven pricing compression can compress the multiple here without touching Andersen's own numbers.
  • Seasonality decouples the name from the broad tape. Q2 is the tax-advisory trough — the quarter carried a GAAP net loss and a 21.1% margin against a 26.8% six-month margin — so quarter-to-quarter comparisons against index performance are noise.
  • Short interest at 26.72% of float with 6.74 days to cover means index-rebalance and passive-flow events can move the stock more than fundamental news, in both directions.

Notes

  • Up-C structure: 98,302,500 non-economic Class B shares carry ten votes each and held ~99% of combined voting power at the IPO.
  • Float is 10.72M shares against 112.99M shares outstanding (stockanalysis.com, 2026-08-16); roughly a tenth of the economics sets the price.
  • GAAP results are distorted by equity-based compensation ($48.3M in Q2 2026); management guides on adjusted EBITDA and adjusted net income.
  • Q2 is the seasonal trough for a tax-advisory firm, so quarterly margin is not comparable to the 23-25% full-year band.
  • The IPO lock-up expired 2026-06-15; pre-IPO and insider supply is no longer contractually restricted.
  • Short-interest percentages differ by vendor because each uses a different float denominator for the Up-C share count.

Related · shared themes

HUM

Humana Inc.

Margin-over-volume Medicare Advantage reset reclaimed its trend: the 2026-08-24 close of $386.61 is 2.0% above the prior session and back clear of the last 50-day value observed ($378.33, 2026-08-12), with RSI(14) at 64.6 from 52.5. Revision flow idle since Bernstein's 08-14 Buy/$425, and the 2027 number now has a venue — a 2026-12-10 investor update — past both the 09-08/10 conference window and the 11-06 print. The narrative is maturing.

MEDIUM

RXO

RXO, Inc.

Freight-cycle recovery intact; sell-side has fully caught up into a $20–35 battleground — bears $20 (Goldman 07-16, Susquehanna 07-14), bulls $30–35 (BMO $35 initiation 07-14, Stifel/Truist/Citi $30). Narrative matured from mispriced to consensus; the ~2026-08-05 Q2 print (adj EBITDA guide $27–37M vs $6M Q1) is the binary the whole re-rate discounts.

MEDIUM

CNC

Centene Corporation

Margin-repair guide raise of 2026-07-28 stays fully priced: the 2026-08-24 close of $65.65 is 2.7% under the 2026-08-14 close of $67.47 and 4.5% below the $68.72 52-week high, with no analyst target moved since Argus on 2026-08-11. maturing; the next company-controlled datapoint is Q3, now calendared 2026-10-27.

LOW

HNGE

Hinge Health, Inc.

Digital-MSK profitability re-rate broke out in May and was pushed into open price discovery by the 2026-06-09 mid-quarter raise (Q2 to $200–202M, +45%; FY26 to $818–824M). But nine sell-side target hikes in two weeks plus accelerating insider selling mark a late, distribution-prone phase, with no company catalyst until the ~2026-08-04 Q2 print.

LOW